Opinion - America has a health care affordability gap. Congress is working toward change.
A resounding majority of voters — nearly 80 percent, according to a recent poll by Fabrizio Ward — say it's time the middle class has a dedicated tool to help them offset runaway health care costs. Yet the complexities and sheer size of our health care system make finding solutions seem insurmountable to many and divisive among the policymakers working toward change.
Even as leaders in Congress are focusing on the myriad of issues driving up the cost of care, such as prescription price hikes, lack of price transparency, and bureaucratic red tape, costs continue to climb. Americans can't afford to wait any longer.
That is why we are reaching across the aisle and supporting the Health Out-of-Pocket Expense Act, or HOPE Act, to give over 100 million eligible Americans the chance to manage their health care expenses. By advancing bipartisan legislation, we can bridge the health care affordability gap, help hardworking Americans receive the care they need, promote better health care outcomes, and work toward becoming a healthier nation.
The HOPE Act, with its broad eligibility and tax advantages, offers a structured and personal way to save for future health needs. The legislation introduces HOPE Accounts, an innovative savings tool designed to help individuals and families plan for medical costs. Individuals and their employers can contribute to a personal account that stays with them forever, untethered to their job, giving people a new way to save for future health expenses, from a routine visit to preventative care to an unforeseen emergency.
Most appealing to Americans is the portability of HOPE Accounts, meaning the funds can never be lost, even when they change jobs. It's security for the long run.
The HOPE Act offers a lifeline for families and individuals who find themselves battling these ever-rising costs, the consequences of which are illustrated both by data and constituent stories. A staggering 45 percent of adults in the U.S. can't afford care when they need it — a 6-point increase since 2022. Families are delaying or altogether skipping out on medical treatment simply out of fear of health care costs, threatening their physical health and adding to anxieties and stress.
Nearly one in three American adults avoided seeking needed care in three months alone, while others, often living paycheck to paycheck, are forced to choose between their health and affording other basic, essential needs from paying off bills and credit cards to buying food for their families.
Worse yet, when care can no longer be avoided, Americans find themselves dipping into their life savings. In the most severe yet all too common cases, patients attempt to buy time by using credit cards or otherwise face medical debt and even bankruptcy.
Americans coming from middle- or lower-income backgrounds are hit hardest, disproportionately affected by out-of-pocket expenses and the consequences of an inability to pay. For these individuals, balancing basic living expenses with unforeseen health care needs can be devastating no matter how hard they work to make ends meet.
The HOPE Act is not a complicated overhaul of the health care system, nor is it a narrow program with eligibility restrictions. It's a straightforward, common-sense solution that empowers families to take control of their health care expenses in a financially responsible way.
As health care costs rise, it is essential for Congress to work toward solutions that not only address the immediate need for affordable care but also equip people from all walks of life with tools that prepare them for future challenges. The HOPE Act does just that, empowering over 100 million people to manage and protect their health. We already have momentum with an endorsement from the Problem Solvers Caucus, a 62-member group evenly split between Republicans and Democrats and committed to advancing solutions by finding common ground. It's time for our other House colleagues to follow suit.
While this solution alone may not completely solve the health care affordability crisis, it is certainly a step in the right direction. Times have seemingly never been more unpredictable. But the HOPE Act is an opportunity for Congress to come together, show bipartisanship, and provide the critical lifeline working families need to take their health, security and futures back into their own hands.
Rep. Blake Moore (R) represents Utah's 1st Congressional District and is a member of the Ways and Means Committee. Jimmy Panetta (D) represents California's 19th Congressional District and is a member of the Ways and Means Committee.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
FTC moves to block Edwards' JenaValve acquisition
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. The Federal Trade Commission has moved to block Edwards Lifesciences' planned acquisition of JenaValve Technology, citing concerns that the deal threatens to reduce competition in the market for devices to treat aortic regurgitation. The agency alleged that over two days in July 2024, Edwards signed agreements to acquire both JenaValve and JC Medical, the two leading companies competing to bring transcatheter aortic valve replacement devices to market to treat the potentially fatal heart condition. Edwards closed the acquisition of JC Medical in August 2024. The FTC said Edwards' proposed $945 million acquisition of JenaValve would combine the only two companies conducting U.S. clinical trials for a TAVR aortic regurgitation, or TAVR-AR, device. 'The deal threatens to reduce competition in the TAVR-AR market, likely resulting in reduced innovation, diminished product quality, and potentially increased prices for consumers,' the agency stated in a federal court complaint. The commission voted 3-0 to issue an administrative complaint and seek a temporary restraining order and a preliminary injunction to halt the transaction pending an administrative proceeding. The complaint and injunction request were filed in the U.S. District Court for the District of Columbia. JenaValve is poised to become the first company to bring a TAVR-AR device, called Trilogy, to the U.S. market, the FTC said. Food and Drug Administration approval of a TAVR-AR device by another company besides Edwards and JenaValve is not expected in the foreseeable future. 'The FTC is taking action to stop this anticompetitive deal and ensure that JenaValve and Edwards' JC Medical subsidiary continue competing to innovate, expand treatment eligibility, and keep down costs,' Daniel Guarnera, director of the FTC's Bureau of Competition, said in the agency's Wednesday statement. Edwards' stance Edwards said Wednesday that it disagrees with the FTC's decision and believes it will limit the treatment options for patients with aortic regurgitation. Edwards argued that the acquisition will actually 'accelerate the availability, adoption and continued innovation of a life-saving treatment for patients suffering from AR.' The company plans to continue to pursue regulatory approval for the deal and expects a final determination by the end of the first quarter of 2026. JenaValve also said that it remains committed to completing the transaction and is confident in the rationale for the merger and the value it will bring to patients. The company intends to join Edwards to defend the case in court. Edwards increased its forecast for 2025 adjusted earnings per share to the high end of a range of $2.45 to $2.55, up from the high end of a range of $2.40 to $2.50, to reflect the impact of the FTC's action. The company said there is no impact to revenue guidance. Edwards agreed to pay $1.2 billion combined in July 2024 to buy JenaValve and Endotronix, which makes an implantable heart failure sensor. With the Endotronix transaction completed, Edwards was expecting the JenaValve deal to close in the middle of this year. Recommended Reading Edwards shrugs off tariffs, backs 2025 profit forecast


Boston Globe
an hour ago
- Boston Globe
Dozens killed seeking aid in Gaza as Israel weighs further military action
Advertisement Another escalation of the nearly 22-month war could put the lives of countless Palestinians and around 20 living Israeli hostages at risk and would draw fierce opposition both internationally and within Israel. Netanyahu's far-right coalition allies have long called for the war to be expanded and for Israel to eventually take over Gaza, relocate much of its population, and rebuild Jewish settlements there. President Trump, asked by a reporter Tuesday whether he supported the reoccupation of Gaza, said he wasn't aware of the 'suggestion' but that 'it's going to be pretty much up to Israel.' Of the 38 Palestinians killed while seeking aid, at least 28 died in the Morag Corridor, an Israeli military zone in southern Gaza where UN convoys have been repeatedly overwhelmed by looters and desperate crowds in recent days, and where witnesses say Israeli forces have repeatedly opened fire. Advertisement The Israeli military said troops fired warning shots as Palestinians advanced toward them, and that it was not aware of any casualties. Nasser Hospital, which received the bodies, said another four people were killed in the Teina area, on a route leading to a site in southern Gaza run by the Israeli-backed Gaza Humanitarian Foundation, an American contractor. The Al-Awda Hospital said it received the bodies of six people killed near a GHF site in central Gaza. GHF said there were no violent incidents at or near its sites and that the one in central Gaza was not open on Wednesday. It said the violence may have been related to the chaos around UN convoys. Two of the Israeli airstrikes hit Gaza City, in the north of the territory, killing 13 people there, including six children and five women, according to the Al-Ahli Hospital, which received the bodies. The Israeli military says it only targets militants and blames civilian deaths on Hamas because its militants are entrenched in heavily populated areas. Israel facilitated the establishment of four GHF sites in May after blocking the entry of all food, medicine, and other goods for 2 1/2 months. Israeli and US officials said a new system was needed to prevent Hamas from siphoning off humanitarian aid. The United Nations, which has delivered aid to hundreds of distribution points across Gaza throughout the war when conditions allow, has rejected the new system, saying it forces Palestinians to travel long distances and risk their lives for food, and that it allows Israel to control who gets aid, potentially using it to advance plans for further mass displacement. Advertisement The UN human rights office said last week that some 1,400 Palestinians have been killed seeking aid since May, mostly near GHF sites but also along UN convoy routes where trucks have been overwhelmed by crowds. It says nearly all were killed by Israeli fire. This week, a group of UN special rapporteurs and independent human rights experts called for the GHF to be disbanded, saying it is 'an utterly disturbing example of how humanitarian relief can be exploited for covert military and geopolitical agendas in serious breach of international law.' The experts work with the UN but do not represent the world body. The GHF called their statement 'disgraceful' and urged the UN and other aid groups to work with it 'to maximize the amount of aid being securely delivered to the Palestinian people in Gaza.' The Israeli military says it has only fired warning shots when crowds threatened its forces, and GHF says its armed contractors have only used pepper spray and fired into the air on some occasions to prevent deadly crowding at its sites. Israel's air and ground war has destroyed nearly all of Gaza's food production capabilities, leaving its people reliant on international aid. A new report by the UN's Food and Agriculture Organization and the UN satellite center found that just 8.6 percent of Gaza's cropland is still accessible following sweeping Israeli evacuation orders in recent months. Just 1.5 percent is accessible and undamaged, it said. The military offensive and a breakdown in security have made it nearly impossible for anyone to safely deliver aid, and aid groups say recent Israeli measures to facilitate more assistance are far from sufficient. Advertisement Hospitals recorded four more malnutrition-related deaths over the last 24 hours, bringing the total to 193 people, including 96 children, since the war began in October 2023, according to the Gaza Health Ministry. Jordan said Israeli settlers blocked roads and hurled stones at a convoy of four trucks carrying aid bound for Gaza after they drove across the border into the Israeli-occupied West Bank. Israeli far-right activists have repeatedly sought to halt aid from entering Gaza. Jordanian government spokesperson Mohammed al-Momani condemned the attack, which he said had shattered the windshields of the trucks, according to the Jordanian state-run Petra News Agency. The Israeli military said security forces went to the scene to disperse the gathering and accompanied the trucks to their destination.


Boston Globe
an hour ago
- Boston Globe
Lucian Leape, whose work spurred patient safety in medicine, dies at 94
He was chief of pediatric surgery at Tufts University in the 1980s when he noticed frequent mistakes leading to significant patient harm, even death. In a bold move late in his career, Dr. Leape left his full-time surgical practice and began collaborating with colleagues at Harvard University on a study that chronicled for the first time the number of injuries and deaths that resulted from medical error. Known as the Harvard Medical Practice Study, it examined a large population of injured patients in New York state. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up That study led to a landmark report, 'To Err Is Human: Building a Safer Health System,' published in 1999 by the Institute of Medicine (now the National Academy of Medicine). Advertisement In the report, Dr. Leape and his co-authors estimated that 44,000 to 98,000 Americans died each year from medical errors, a majority of which arose from dysfunctional systems -- not flawed individuals, as the medical profession and public had long believed. The idea of systemic error, though widely accepted in industries such as aviation and nuclear power, was an unfamiliar concept in medicine, and it rubbed against the grain of the dominant medical culture of individual accountability, as well as the malpractice system's tradition of seeking a culpable clinician. Advertisement The report, however, galvanized health care regulators and accreditors to enact tighter standards for hospitals, limit work hours by medical residents, and require public reporting of serious errors. As a result of regulations and public pressure, health care systems around the country began to tackle medical mistakes as a system-level problem, launching patient safety departments and hiring patient safety officers. 'He did more than make some critical insights,' Dr. Atul Gawande, a prominent surgeon and author who was assistant administrator for global health at the US Agency for International Development in the Biden administration, said in a 2023 interview for this obituary. 'He took on the entire medical profession.' Lucian L. Leape (he had no middle name, though the 'L' was included on his birth certificate) was born Nov. 7, 1930, in Bellevue, Pa. His father, Lucian Leroy Leape, was a purchasing agent for a small steel company. His mother, Mildred Grace (West) Leape, was a schoolteacher who later taught piano. After receiving his undergraduate degree in chemistry from Cornell University in 1952, he served as a lieutenant in the Navy, and in 1955 entered Harvard Medical School. He met Martha Kinne Palmer in 1951, when both were undergraduates at Cornell, and they married in 1954. Martha Leape, who held master's degrees in guidance counseling and psychology, became a premedical adviser at Harvard University and later ran the university's office of career services. She died this year. In addition to his son James, Dr. Leape leaves two other sons, Jonathan and Gerald, and seven grandchildren. Advertisement After receiving his medical degree in 1959, Dr. Leape trained as a pediatric surgeon at Massachusetts General Hospital and Children's Hospital in Boston. In 1973, he became professor of surgery at Tufts University School of Medicine and chief of pediatric surgery at Tufts-New England Medical Center (now Tufts Medical Center). 'Children are the world's best patients,' he said in an interview for this obituary in 2015. 'They're honest, and they don't have an overlay of neuroses.' In 1986, at age 56, Dr. Leape grew interested in health policy and spent a year at the Rand Corp. on a midcareer fellowship studying epidemiology, statistics, and health policy. Following his stint at Rand, he joined the team at Harvard conducting the Medical Practice Study. When Dr. Howard Hiatt, then the dean of the Harvard School of Public Health (now the Harvard T.H. Chan School of Public Health), offered Dr. Leape the opportunity to work on the study, 'I accepted,' Dr. Leape wrote in his 2021 book, 'Making Healthcare Safe: The Story of the Patient Safety Movement,' 'not suspecting it would change my life.' The most significant finding, he said in the 2015 interview, was that two-thirds of the injuries to patients were caused by errors that appeared to be preventable. 'The implications were profound,' he said. In 1994, he submitted a paper to The New England Journal of Medicine, laying out the extent to which preventable medical injury occurred and arguing for a shift of focus away from individuals and toward systems. But the paper was rejected. 'I was told it didn't meet their standards,' he recalled. Dr. Leape sent the paper out again, this time to The Journal of the American Medical Association. Dr. George Lundberg, then the editor of JAMA, immediately recognized the importance of the topic, Dr. Leape said. 'But he also knew it could offend many doctors. We didn't talk about mistakes.' Advertisement Dr. Donald M. Berwick, president emeritus at the Institute for Healthcare Improvement in Boston and a longtime colleague of Dr. Leape's, agreed. 'To talk about error in medicine back then was considered rude,' he said in an interview in 2020. 'Errors were what we call normalized. Bad things happen, and that's just the way it is. 'But then you had Lucian,' he added, 'this quite different voice in the room saying, 'No, this isn't normal. And we can do something about it.'' Dr. Leape's paper, 'Error in Medicine,' was the first major article on the topic in the general medical literature. The timing of publication, just before Christmas in 1994, Dr. Leape wrote in his 2021 book, was intentional. Lundberg knew it would receive little attention and therefore wouldn't upset colleagues. On Dec. 3, 1994, however, three weeks before the JAMA piece appeared, Betsy Lehman, a 39-year-old health care reporter for The Boston Globe, died after mistakenly receiving a fatal overdose of chemotherapy at the Dana-Farber Cancer Institute in Boston. 'Betsy's death was a watershed event,' Dr. Leape said in a 2020 interview for a short documentary about Lehman. The case drew national attention. An investigation into the death revealed that it wasn't caused by one individual clinician, but by a series of errors involving multiple physicians and nurses who had misinterpreted a four-day regimen as a single dose, administering quadruple the prescribed amount. The case made Dr. Leape's point with tragic clarity: Lehman's death, like so many others, resulted from a system that lacked sufficient safeguards to prevent the error. Advertisement The report 'To Err is Human' was released in 1999, noting that the 44,000 to 98,000 annual deaths from medical mistakes were the equivalent of a jumbo jet crashing every day. That alarming comparison drew significant media attention, and the report led to substantial new federal funding to address the problem of medical errors, along with efforts to educate providers and administrators about the new systems approach to errors. 'There might have developed a patient safety movement in health care without Lucian, but he made it happen years before it otherwise would have,' Berwick said. 'He was probably the first pedigreed specialist from the mainstream of health care to give this problem a name.' Gawande said he believed it was the confidence Dr. Leape had acquired as a surgeon that girded him in the face of strong resistance from colleagues. 'He had enough arrogance to believe in himself and in what he was saying,' Gawande said. 'He knew he was onto something important, and that he could bring the profession along, partly by goading the profession as much as anything.' In 2007, the National Patient Safety Foundation, which Dr. Leape had helped found in 1997 to support the growth of the nascent field, created a patient safety think tank, the Lucian Leape Institute, which is now part of the Institute for Healthcare Improvement. This article originally appeared in